Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17270245rdf:typepubmed:Citationlld:pubmed
pubmed-article:17270245lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:17270245lifeskim:mentionsumls-concept:C0007115lld:lifeskim
pubmed-article:17270245lifeskim:mentionsumls-concept:C0813143lld:lifeskim
pubmed-article:17270245lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:17270245lifeskim:mentionsumls-concept:C1521871lld:lifeskim
pubmed-article:17270245pubmed:issue4lld:pubmed
pubmed-article:17270245pubmed:dateCreated2007-3-19lld:pubmed
pubmed-article:17270245pubmed:abstractTextA radiation etiology is well known in thyroid carcinogenesis. RET oncogene rearrangement is the most common oncogenic alteration in Chernobyl-related papillary thyroid cancer (PTC). To find the characteristic alteration associated with RET rearrangements in radiation-induced thyroid cancers, we analyzed the RET oncogene by fluorescence in situ hybridization. The fluorescence in situ hybridization technique has the possibility of detecting RET rearrangements at a single-cell level regardless of the specific fusion partner involved and directly reveals RET copy number on a per-cell basis. Our study demonstrated RET amplification in all 3 cases of radiation-associated thyroid cancers but not in sporadic well-differentiated PTC (n = 11). Furthermore, RET amplification was observed in all 6 cases of sporadic anaplastic thyroid cancers (ATCs). The frequency of RET amplification-positive cells was higher in ATC (7.2%-24.1%) than in PTC (1.5%-2.7%). The highest frequency of RET amplification-positive cells was observed among ATC cases with a strong p53 immunoreactivity. In conclusion, we found RET amplification, which is a rare oncogenic aberration, in thyroid cancer. This report is the first one to suggest the presence of RET amplification in PTC and ATC. RET amplification was correlated with radiation-associated, high-grade malignant potency, and p53 accumulation, suggesting genomic instability. RET amplification might be induced by a high level of genomic instability in connection with progression of thyroid carcinogenesis and, subsequently, be associated with radiation-induced and/or high-grade malignant cases.lld:pubmed
pubmed-article:17270245pubmed:languageenglld:pubmed
pubmed-article:17270245pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17270245pubmed:citationSubsetIMlld:pubmed
pubmed-article:17270245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17270245pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17270245pubmed:statusMEDLINElld:pubmed
pubmed-article:17270245pubmed:monthAprlld:pubmed
pubmed-article:17270245pubmed:issn0046-8177lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:NakashimaMasa...lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:SekineIchiroIlld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:HayashiTomayo...lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:MatsumotoNaom...lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:MaedaShigetoSlld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:NambaHiroyuki...lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:TakamuraNobor...lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:MeirmanovSeri...lld:pubmed
pubmed-article:17270245pubmed:authorpubmed-author:SaenkoVladimi...lld:pubmed
pubmed-article:17270245pubmed:issnTypePrintlld:pubmed
pubmed-article:17270245pubmed:volume38lld:pubmed
pubmed-article:17270245pubmed:ownerNLMlld:pubmed
pubmed-article:17270245pubmed:authorsCompleteYlld:pubmed
pubmed-article:17270245pubmed:pagination621-8lld:pubmed
pubmed-article:17270245pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:meshHeadingpubmed-meshheading:17270245...lld:pubmed
pubmed-article:17270245pubmed:year2007lld:pubmed
pubmed-article:17270245pubmed:articleTitleRET oncogene amplification in thyroid cancer: correlations with radiation-associated and high-grade malignancy.lld:pubmed
pubmed-article:17270245pubmed:affiliationTissue and Histopathology Section, Division of Scientific Data Registry, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan. moemoe@nagasaki-u.ac.jplld:pubmed
pubmed-article:17270245pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17270245pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5979entrezgene:pubmedpubmed-article:17270245lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:17270245lld:entrezgene
lhgdn:association:18438lhgdn:found_inpubmed-article:17270245lld:lhgdn
lhgdn:association:18448lhgdn:found_inpubmed-article:17270245lld:lhgdn
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17270245lld:pubmed